Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Soc Sci Med. 2012 Mar 13;74(10):1584–1590. doi: 10.1016/j.socscimed.2012.02.012

Table 3.

Association between APOE-E4 genotype and cognitive decline by neighborhood disorder.

Level of neighborhood social disorder

Low High
Intercept −.308*** (.039) −.187*** (.049)
Baseline cognitive function −.174*** (.030) −.169*** (.019)
APOE-E4 Genotype −.186*** (.027) −.083*** (.021)
Neighborhood disadvantage −.087** (.030) −.080 (.045)
Respondent race [Black = 1] .086 (.046) −.038 (.042)
Respondent education (std.) −.027 (.015) .033** (.012)
Respondent age (std.) −.293*** (.015) −.245*** (.015)
Respondent sex [Male = 1] .063* (.025) −.027 (.022)
Duration of residence .045*** (.011) .064** *(.013)
Follow-up time −.057*** (.013) −.053*** (.012)

−2LL 2532.806 3362.590
Likelihood ratio 12.230 2.872
df 1 1
p < .000 .090

Note: all data have been weighted to correct for sampling design of the Chicago Health and Aging Project. Cell entries denote random intercepts models that capture differences in the mean level of cognitive function across neighborhoods. A random slope for APOE-E4 genotype is not estimated in these models. The likelihood ratios compare the -2LogLikelihood estimates of the current model to the prior baseline model. Corresponding degrees of freedom and probability of overall model improvement are provided.

***

p < .001,

**

p < .01,

*

p < .05.